Thomas E. D'Ambra Ph.D., Director at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 20,000 shares at $18.50 ($370K) on 2015-04-10, disclosed to the SEC on 2015-04-14.
Scheduled sale ($370k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMRI | SELL | 2015-03-11 | $353K | — | Filing → |
| AMRI | SELL | 2015-02-12 | $338K | — | Filing → |
| AMRI | SELL | 2015-01-13 | $329K | — | Filing → |